Overall result forecast presentation:	yes
Quantity performed reporting year:	30
Quantity forecast year:	21
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	59
Quantity forecast year:	56
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ05	Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ02	Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: yes

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
78	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
16	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
Measures
- Prevention
  Training of employees
  Note on the measure
  Fortbildungen zum Thema Basiswissen u.a. zum Erkennen von (sexueller) Gewalt und Einleitung entsprechender Hilfen, inkl. des Erwerbs von Wissen zu gesetzlichen Pflichten und zur Durchbrechung der ärztlichen Schweigepflicht bei Verdacht auf Gefährdung des Kindeswohls
  Age-appropriate complaint options
  Special requirements for the selection of persons
  Note on the measure
  Erweitertes Führungszeugnis bei Einstellung
  Code of conduct with rules for treating children and young people with respect
  Last review of the measure
  23.12.2022 16:01:35
  Education
- Intervention
  Intervention plan - Binding procedure for dealing with child protection cases and in particular suspected (sexual) violence
  Note on the measure
  Kinderschutzkonzept für alle im Intranet zugängig
  
  Last review of the measure
  15.12.2022 16:01:35
- Review
  Recommendations for dealing with/processing cases that have occurred
  Note on the measure
  Eskalationsplan
  
  Last review of the measure
  15.12.2022 16:01:35

Fortbildungen zum Thema Basiswissen u.a. zum Erkennen von (sexueller) Gewalt und Einleitung entsprechender Hilfen, inkl. des Erwerbs von Wissen zu gesetzlichen Pflichten und zur Durchbrechung der ärztlichen Schweigepflicht bei Verdacht auf Gefährdung des Kindeswohls

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
Online Bestellung

Measures to minimise medication errors

Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL04 - Project-related cooperation with colleges and universities

Explanation

FL09 - Doctoral supervision

Explanation

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

FL03 - Student training (clinical traineeship / internship year)

Explanation

FL02 - Lectureships / teaching posts at universities of applied sciences

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

FL08 - Editors of scientific journals/textbooks

Explanation

Training

Training in other healing professions

HB12 - Medical technical laboratory assistant (MTLA) (m/f)

Comment

HB01 - Nurse and health care worker (m/f)

Comment

HB10 - Midwife (m/f)

Comment

HB02 - Health and paediatric nurse (m/f)

Comment

HB07 - Surgical technical assistant (m/f)

Comment

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 1
- Explanations: Kooperation mit externer Apotheke
- Nursing staff regulation

Service contact persons

Customer feedback management

Andrea Halberschmidt

Qualitätsmanagerin

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5058
Mail: ed.oenokaid@tdimhcsreblah.aerdna

Quality management

Andrea Halberschmidt

Qualitätsmanagerin

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5058
Mail: ed.oenokaid@tdimhcsreblah.aerdna

Hygiene officer

Dr. Karin Becke-Jakob

Chefärztin Anästhesie und Intensivmedizin

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-4900
Mail: ed.oenokaid@reyem.ekirlu

Prof. Dr. Michael Kranzfelder

Chefarzt Allgemein- und Viszeralchirurgie

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-2600
Mail: ed.oenokaid@hcirdeirf.enibas

Responsible for drug therapy

Mag. pharm. Wilhelm Bouhon

externer Apotheker , Kooperationspartner Mohren Apotheke

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -206-330
Mail: gro.ekehtopA-nerhoM@nohuoB.mlehliW

Accessibility Officer

Andrea Halberschmidt

Qualitätsmanagement

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5058
Mail: ed.oenokaid@tdimhcsreblah.aerdna

Company

General contact details of the hospital

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911-3340-0
Fax: 0911-3340-5001
Mail: ed.oenokaid@gnutuel.ramgni

Nursing service management

Sabrina Breternitz

Pflegedirektorin

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5004
Mail: ed.oenokaid@ztinreterB.anirbaS

Aylin Brauer

Stellvertretende Pflegedienstleitung

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5005
Mail: ed.oenokaid@reuarB.nilyA

Head of administration

Martina Keßler

Verwaltungsleitung

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5010
Mail: ed.oenokaid@relsseK.anitraM

Peter Rahn

Geschäftsführender Leiter

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5009
Mail: ed.oenokaid@nhaR.reteP

Responsible for the quality report in the hospital management

Peter Rahn

Geschäftsführender Leiter

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-5010
Mail: ed.oenokaid@gnutuel.ramgni

Medical management

Prof. Dr. med. Michael Schroth

Chefarzt Kinder- und Jugendmedizin, ärztlicher Direktor Cnopfsche Kinderklinik

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-3240
Mail: ed.oenokaid@yksvoson.ajnos

Dr. med. Karin Becke-Jakob

Chefärztin Anästhesie und Kinderanästhesie, Intensivmedizin und ärztliche Direktorin Klinik Hallerwiese

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-4900
Mail: ed.oenokaid@reyem.ekirlu

Prof. Dr. med. Michael Kranzfelder

Chefarzt Abteilung Allgemein- und Viszeralchirurgie, Ärztlicher Direktor Klinik Hallerwiese

St.-Johannis-Mühlgasse 19
90419 Nürnberg

Phone: 0911 -3340-2600
Mail: ed.oenokaid@hcirdeirf.enibas

Regional care obligation for psychiatry?

IK number

IK: 260900338

Location number

Location number: 771453000

Old location number: 771453000